SCHEMBL3637211

SCHEMBL3637211

O=C1CCN(S(=O)(=O)c2ccc(C(F)(F)F)cc2)C1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.55
HDAC6 Q9UBN7 1/20 0.53
KMT2A Q03164 5/20 0.51
MEN1 O00255 4/20 0.49
GAA P10253 3/20 0.48
EPHX2 P34913 3/20 0.47
HSD11B1 P28845 1/20 0.46
KDM4E B2RXH2 1/20 0.46
NOX4 Q9NPH5 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
LMNA P02545 2/20 0.45
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NAMPT P43490 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12655864 0.90 KMT2A (0.63) ALDH1A1HDAC6KMT2AMEN1GAA
SCHEMBL8219715 0.79 ALDH1A1 (0.60) ALDH1A1HDAC6KMT2AMEN1GAA
SCHEMBL265611 0.79 PKM (0.61) ALDH1A1KMT2AMEN1GAALMNA
SCHEMBL6559970 0.79 KMT2A (0.56) ALDH1A1KMT2AMEN1
SCHEMBL15009887 0.78 ALDH1A1 (0.77) ALDH1A1KMT2AMEN1GAAEPHX2
SCHEMBL28254937 0.77 ALDH1A1 (0.74) ALDH1A1KMT2AMEN1GAAEPHX2
SCHEMBL693876 0.76 HDAC6 (0.56) ALDH1A1HDAC6KMT2AMEN1GAA
SCHEMBL20046992 0.76 HDAC6 (0.69) ALDH1A1HDAC6KMT2AMEN1GAA
SCHEMBL2299332 0.75 KMT2A (0.51) ALDH1A1KMT2AMEN1GAAEPHX2
SCHEMBL24295449 0.74 EPHX2 (0.75) ALDH1A1KMT2AMEN1GAAEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2152713-A1 PYRAZOLOPYRROLIDINES AS INHIBITORS OF GAMMA SECRETASE Elan Pharmaceuticals Inc. (US) 2010-02-17 EP disclosed
WO-2008147800-A1 PYRAZOLOPYRROLIDINES AS INHIBITORS OF GAMMA SECRETASE ELAN PHARMACEUTICALS, INC. (US) 2008-12-04 WO disclosed